Skip to Content

Myozyme Approved - Genzyme Corp. - Treatment for Pompe Disease

Myozyme is a recombinant formulation of the human enzyme acid alpha-glucosidase (GAA) indicated for use in patients with Pompe disease (GAA deficiency), a debilitating and often fatal muscle disorder.

Posted: April 2006

Related Articles:

Myozyme (alglucosidase alfa) FDA Approval History

View comments